University of Birmingham
Birmingham, B5 7EG, United Kingdom
NCT Number: NCT03598881
This study is to compare the effect on oral mucosal desquamation of a non-SLS toothpaste and an SLS-containing toothpaste..
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Birmingham, B5 7EG, United Kingdom
Subjects will use a wash out toothpaste for at least 10 days prior to each leg of the crossover design. Clinical assessment of oral mucosa status will be performed by a trained examiner before supervised product application, 30 minutes after product application and again after 4 days of twice daily brushing with product. Supervised product application consists of cap splint application of allocated toothpaste to maxillary arch followed by brushing whole mouth with toothpaste and swishing with resultant slurry around the mouth.
For visual sloughing evaluation, the oral mucosa will be divided into 12 assessment areas and each area evaluated for severity of sloughing on a 0 to 5 scale.
The following outcomes will be generated from the sloughing data:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 minutes
Total lesion count aggregated across all subjects
Time frame: 4 days
Total lesion count aggregated across all subjects
Time frame: 30 minutes
Subject level mucosal severity sloughing score
Time frame: 4 days
Subject level mucosal severity sloughing score
Unilever R&D
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05106738
C-reactive Protein, Digestive System Diseases
Bari, BA, Italy
View Trial DetailsNCT04814927
Contraceptive; Complications, Intrauterine, Digestive System Diseases
Norfolk, Virginia, United States
View Trial DetailsNCT07045636
Communicable Diseases, Digestive System Diseases
Guarulhos, São Paulo, Brazil
View Trial DetailsNCT04251949
Digestive System Diseases, Gastroenteritis
Lille, France
View Trial Details